4
Changes in Ownership
Lycia Therapeutics, Inc. Filed Acc 0002010805-26-000007
Options or other derivatives
- Chief Medical Officer acquired 73,191 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lee Chin Hyok Chief Medical Officer | 2026-08-11 | Grant or award · Stock Option (Right to Buy) | +73,191 | 73,191 | D | ||
Loading xslF345X06/form4-10262026_111002.xml…